While the use of synthetic control arms has been limited to date, and in many cases has required manual chart review to generate the necessary data, there is clear regulatory precedent for using them.

2006-06-02T04:06:39-04:00https://images.c-span.org/Files/f0e/192793-m.jpgThe Officials released the first Synthetic Drug Control Strategy, which provides a ...

Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “Our synthetic controls, including the H5N1 Influenza A control, enable broader research access without the need for live viruses.